462
Views
10
CrossRef citations to date
0
Altmetric
Review

Evaluation of coronary plaques and atherosclerosis using optical coherence tomography

, &
Pages 379-386 | Received 13 Nov 2020, Accepted 06 Apr 2021, Published online: 21 Apr 2021

References

  • Di Mario C, Moreno PR. Invasive coronary imaging: any role in primary and secondary prevention? Eur Heart J. 2016;37:1883–1890.
  • Komukai K, Kubo T, Kitabata H, et al. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography. J Am Coll Cardiol. 2014;64(21):2207–2217.
  • Nicholls SJ, Puri R, Anderson T, et al. Effect of evolocumab on progression of coronary disease in statin-treated patients. JAMA. 2016;316(22):2373–2384.
  • Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-I (Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation. 2001;103:3047–3050.
  • Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087–1099.
  • Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the. International working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012;59:1058–1072.
  • Prati F, Cera M, Ramazzotti V, et al. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention. 2007;3:365–370.
  • Taniwaki M, Radu MD, Garcia-Garcia HM, et al. Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. Int J Cardiovasc Imaging. 2015;31:915–926.
  • Xu C, Schmitt JM, Carlier SG, et al. Characterization of atherosclerosis plaque by measuring both backscattering and attenuation coefficients in optical coherence tomography. J Biomed Opt. 2008;13:034003.
  • Milzi A, Burgmaier M, Burgmaier K, et al. Type 2 diabetes mellitus is associated with a lower fibrous cap thickness but has no impact on calcification morphology: an intracoronary optical coherence tomography study. Cardio. Dia. 2017;16:152.
  • Brahimi P, Jashari F, Nicoll R, et al. Coronary and carotid atherosclerosis: how useful is the imaging? Atherosclerosis. 2013;231:323–333.
  • Mori H, Torii S, Kutyuna M, et al. Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging. 2018;11:127–142.
  • Kobayashi Y, Okura H, Kume T, et al. Impact of target lesion coronary calcification on stent expansion. Circ J. 2014;78:2209–2214.
  • Mintz GS. Intravascular imaging of coronary calcification and its clinical implications. JACC Cardiovasc Imaging. 2015;8:461–471.
  • Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106:1640–1645.
  • Manfrini O, Mont E, Leone O, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol. 2006;98:156–159.
  • Kawasaki M, Bouma BE, Bressner J, et al. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol. 2006;48:81–88.
  • Rieber J, Meer O, Babaryka G, et al. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron Artery Dis. 2006;17:425–430.
  • Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol. 2006;97:1172–1175.
  • Brown AJ, Obaid DR, Costopoulos C, et al. Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ. Cardio. Imaging. 2015;8:e003487.
  • Fujino A, Mintz GS, Matsumura M, et al. A new optical coherence tomography-based calcium scoring system to predict stent underexpansion. EuroIntervention. 2018;13:e2182–9.
  • Tanaka A, Imanishi T, Kitabata H, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J. 2009;30:1348–1355.
  • Soeda T, Higuma T, Abe N, et al. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture. Eur Heart J Cardiovasc Imaging. 2017;18:103–110.
  • Ino Y, Kubo T, Matsuo Y, et al. Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation. Circ Cardiovasc Interv. 2016;9:e004231.
  • Kubo T, Shinke T, Okamura T, et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38:3139–3147.
  • Ali Z, Landmesser U, Galougahi KK, et al. Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI - design and rationale of ILUMIEN IV: OPTIMAL PCI. Eurointervention. 2021;16:1092–1099.
  • Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733–743.
  • Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004;25:1077–1082.
  • Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–1275.
  • Kolodgie FD, Burke AP, Farb A, et al. The thin cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion of acute coronary syndromes. Curr Opin Cardiol. 2001;16:285–292.
  • Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004;110:2032–2038.
  • Phipps JE, Hoyt T, Vela D, et al. Diagnosis of thin-capped fibroatheromas in intravascular optical coherence tomography images: effects of light scattering. Circ Cardiovasc Interv. 2016;9:e003163.
  • Phipps JE, Vela D, Hoyt T, et al. Macrophages and intravascular bright spots: a quantitative study. JACC Cardiovasc Imaging. 2015;8:63–72.
  • Katayama Y, Tanaka A, Taruya A, et al. Feasibility and clinical significance of in vivo cholesterol crystal detection using optical coherence tomography. Arterioscler Thromb Vasc Biol. 2020;40:220–229.
  • Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316–2325.
  • Barger AC, Beeuwkes R 3rd. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol. 1990;66:41G–3G.
  • Taruya A, Tanaka A, Nishiguchi T, et al. Vasa vasorum restructuring in human atherosclerotic plaque vulnerability: a clinical optical coherence tomography study. J Am Coll Cardiol. 2015;65:2469–2477.
  • Prati F, Romagnoli E, Gatto L, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41:383–391.
  • Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36:2147–2159.
  • Stettler R, Dijkstra J, Räber L, et al. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study. EuroIntervention. 2018;13:e1831–40.
  • Nakamura D, Yasumura K, Nakamura H, et al. Different neoatherosclerosis patterns in drug-eluting- and bare-metal stent restenosis - optical coherence tomography study. Circ J. 2019;83:313–319.
  • Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol. 2006;97:1713–1717.
  • Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748–1758.
  • Jia H, Kubo T, Akasaka T, et al. Optical coherence tomography guidance in management of acute coronary syndrome caused by plaque erosion. Circ J. 2018;82:302–308.
  • Khalifa AKM, Kubo T, Ino Y, et al. Optical coherence tomography comparison of percutaneous coronary intervention among plaque rupture, erosion, and calcified nodule in acute myocardial infarction. Circ J. 2020;84:911–916.
  • Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
  • Niccoli G, Montone RA, Di Vito L, et al. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur Heart J. 2015;22:1377–1384.
  • Yonetsu T, Lee T, Murai T, et al. Plaque morphologies and the clinical prognosis of acute coronary syndrome caused by lesions with intact fibrous cap diagnosed by optical coherence tomography. Int J Cardiol. 2016;203:766–774.
  • Jia H, Dai J, Hou J, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J. 2017;38:792–800.
  • Xing L, Yamamoto E, Sugiyama T, et al. EROSION study (effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion) A 1-year follow-up report. Circ Cardiovasc Interv. 2017;10:e005860.
  • Shlofmitz E, Sosa FA, Ali ZA, et al. OCT-guided treatment of calcified coronary artery disease: breaking the barrier to stent expansion. Curr. Cardiovasc. Imaging. Rep. 2019;12:32.
  • Van Der Sijde JN, Guagliumi G, Sirbu V, et al. The OPTIS integrated system: real-time, co-registration of angiography and optical coherence tomography. Eurointervention. 2016;12:855–860.
  • Schneider VS, Böhm F, Blum K, et al. Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial. Clin Res Cardiol. 2021;110:249–257.
  • Prati F, Romagnoli E, Burzotta F, et al. Clinical impact of OCT findings during PCI: the CLI-OPCI II Study. JACC Cardiovasc Imaging. 2015;8:1297–1305.
  • Kubo T, Tanaka A, Kitabata H, et al. Application of optical coherence tomography in percutaneous coronary intervention. Circ J. 2012;76:2076–2083.
  • Ali ZA, Maehara A, Philippe Généreux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388:2618–2628.
  • Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016;37:1208–1216.
  • Meneveau N, Souteyrand G, Motreff P, et al. Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (does optical coherence tomography optimize results of stenting). Circulation. 2016;134:906–917.
  • De Boer JF, Hitzenberger CK, Yasuno Y. Polarization sensitive optical coherence tomography- a review [Invited]. Biomed Opt Express. 2017;8:1838–1873.
  • Giattina SD, Courtney BK, Herz PR, et al. Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int J Cardiol. 2006;107:400–409.
  • Fard AM, Vacas-Jacques P, Hamidi E, et al. Optical coherence tomography-near infrared spectroscopy system and catheter for intravascular imaging. Opt Express. 2013;21:30849–30858.
  • Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17:1680–1684.
  • Ughi GJ, Wang H, Gerbaud E, et al. Clinical characterization of coronary atherosclerosis with dual-modality OCT and near-infrared autofluorescence imaging. JACC Cardiovasc Imaging. 2016;9:1304–1314.
  • Chu M, Jia H, Gutiérrez-Chico JL, et al. Automatic characterisation of human atherosclerotic plaque composition from intravascular optical coherence tomography using artificial intelligence. Eurointervention. 2021 Feb 2;EIJ-D-20-01355. Online ahead of print 10.4244/EIJ-D-20-01355
  • Lee J, Prabhu D, Kolluru C, et al. Fully automated plaque characterization in intravascular OCT images using hybrid convolutional and lumen morphology features. Sci Rep. 2020;10:2596. Published online 2020 Feb 13
  • Al-Mallah MH, Sakr S. Artificial intelligence for plaque characterization: a scientific exercise looking for a clinical application. Athero 2019 Sep;288:158–159. Epub 2019 Jun 29

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.